Literature DB >> 3921780

Fulminant hepatitis: Mayo Clinic experience with 34 cases.

J Rakela, S M Lange, J Ludwig, W P Baldus.   

Abstract

From 1974 through 1982, fulminant hepatitis was diagnosed in 34 patients at our institution. Of these patients, only two survived (survival rate, 6%). This syndrome was caused by viruses (B and non-B hepatitis and herpes simplex) in 23 patients, hepatotoxic drug in 6, Wilson's disease (hepatolenticular degeneration) in 3, and industrial poisons in 2. Most of the patients died within 10 days after the onset of encephalopathy. The poor prognosis in our group of patients was probably related to the preponderance of older patients and cases caused by non-B hepatitis virus. In our patients, the clinical course was complicated by renal failure, ascites, bleeding, sepsis, pancreatitis, and seizures. The major cause of death was hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921780     DOI: 10.1016/s0025-6196(12)60534-5

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  27 in total

Review 1.  Cell therapies for liver diseases.

Authors:  Yue Yu; James E Fisher; Joseph B Lillegard; Brian Rodysill; Bruce Amiot; Scott L Nyberg
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

2.  Inhibitors of hepatic DNA synthesis in fulminant hepatic failure.

Authors:  R D Hughes; H Yamada; C D Gove; R Williams
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

Review 3.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 4.  Liver regeneration in relationship to acute liver failure.

Authors:  C D Gove; R D Hughes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

5.  Kaposi's varicelliform eruption.

Authors:  Zaw Min; John W Gnann
Journal:  Intern Emerg Med       Date:  2013-09-14       Impact factor: 3.397

6.  Inhibition of nitric oxide production and the effects of arginine and Lactobacillus administration in an acute liver injury model.

Authors:  D Adawi; G Molin; B Jeppsson
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

Review 7.  Fulminant hepatic failure.

Authors:  R J Yanda
Journal:  West J Med       Date:  1988-11

8.  Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States.

Authors:  N H Urrunaga; V P Rachakonda; L S Magder; A L Mindikoglu
Journal:  Transplant Proc       Date:  2014 Jan-Feb       Impact factor: 1.066

9.  Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube.

Authors:  Dmitry Frank; Shiri Savir; Benjamin F Gruenbaum; Israel Melamed; Julia Grinshpun; Ruslan Kuts; Boris Knyazer; Alexander Zlotnik; Max Vinokur; Matthew Boyko
Journal:  J Vis Exp       Date:  2020-04-28       Impact factor: 1.355

10.  Prospective assessment of incidence of fulminant hepatitis in post-transfusion hepatitis: a study of 504 cases.

Authors:  S Takano; M Omata; M Ohto; Y Satomura
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.